Researchers at the University of Turku in Finland have found a new function for an existing protein. They discovered that TIMP-1, a protein...
Vous n'êtes pas connecté
Researchers at Baylor College of Medicine and collaborating institutions have uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets, expanding the breadth of possibilities for treating this disease. Using a comprehensive approach that included integrating proteomics, genomics and epigenomics data from 10 cancer types, the team identified protein and [...]
Researchers at the University of Turku in Finland have found a new function for an existing protein. They discovered that TIMP-1, a protein...
Researchers at Baylor College of Medicine, the University of Cambridge in the U.K. and collaborating institutions have shown that serotonin 2C...
Researchers at Massachusetts General Hospital have uncovered a promising new approach to stroke therapy using non-invasive laser light treatment....
Researchers at Massachusetts General Hospital have uncovered a promising new approach to stroke therapy using non-invasive laser light treatment....
Other medicines were approved to treat a rare eye disease, kidney failure and to aid fertility treatments.
Researchers have identified a Vascular Endothelial Growth Factor Receptor (VEGFR) that could lead to new treatments for colon and renal cancers. ...
RIKEN Center and Kyoto University, using ReapTEC, identified T cell enhancers in rare helper T cells linked to immune conditions. Published in...
UC San Francisco researchers discovered a unique protein pattern in spinal fluid that aids in new treatments for progressive supranuclear palsy.
Researchers discover that pancreatic cancer's chemoresistance is linked to tissue stiffness and CD44 receptors, suggesting new drug targets.
Two Scion research projects have been awarded Catalyst: Seeding funding for projects in collaboration with United States and United Kingdom research...